Westchester Capital Management (New York)’s Allergan plc AGN Stock Holding History

Westchester Capital Management (New York)’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-36,300	Closed	-$7.62M	–	107
2016 Q4	$7.62M	Sell	36,300 -66,500	-65%	-$13.8M	0.19%	68
2016 Q3	$23.7M	Sell	102,800 -119,000	-54%	-$29.1M	0.68%	44
2016 Q2	$51.3M	Buy	221,800 +191,800	+639%	+$44.2M	1.18%	31
2016 Q1	$8.04M	Buy	+30,000	New	+$8.59M	0.16%	64

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Westchester Capital Management (New York)'s AGN Position: Q2 2020 in Review

Westchester Capital Management (New York) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 106,988 shares — an estimated $18.9M sold.

Westchester Capital Management (New York) first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $214M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Westchester Capital Management (New York) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Westchester Capital Management (New York) sold 106,988 Allergan plc shares in Q2 2020, an estimated $18.9M.
Westchester Capital Management (New York) first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
Westchester Capital Management (New York)'s Allergan plc position peaked at $214M in Q4 2019.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.